Supplemental File: Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy

Published: 16 December 2022| Version 1 | DOI: 10.17632/mrdyhdh78k.1
Contributors:
Maria Asdourian, Ted Jacoby, Nishi Shah, Tracey Otto, Leah Thompson, Edward Christopher Dee, Kerry Reynolds, Yevgeniy Semenov, Steven Chen

Description

This file includes additional details on study methodology and supplemental figures (Kaplan-Meier curves).

Files

Categories

Dermatology, Cancer Immunotherapy, Drug Adverse Reactions, Survival Analysis, Medical Oncology

Licence